EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Compliance to Competitive Advantage in Pharma Supply

    Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser

KNOWLEDGE BANK

  • Articles

    How Cloud Computing and AI Revolutionize Pharmaceutical Supply Chain Management

    The pharma supply chain management has been considered as one of the most complicated spheres of operations in any industry As opposed to the traditional supply chain pharmaceutical supply chains have to juggle patient safety regulatory compliance cold chain integrity global sourcing and unpredictable demand and cost pressures simultaneously

    Innovative Pricing Models in the EU: Making Medicines Affordable for All

    Pricing policies are important determinants in delivering sufficiently cheap medicines in all the member nations of the EU High costs of meeting the required medical care together with arising independent differentiated technological improvements have rendered exhausted pricing structures as uncompetitive tools for fairness New mechanisms of pricing have been introduced

    Unveiling the Revolutionary Potential: Exploring Blockchain Technology in Pharma

    The pharmaceutical industry is renowned for its stringent regulations complex supply chains and crucial emphasis on data integrity In recent years the emergence of blockchain technology has sparked considerable interest

    Advancing Pharmacovigilance Talent for AI: Overcoming Skills and Resource Barriers

    In the transforming field of pharmacovigilance PV artificial intelligence AI is reshaping how drug safety is monitored and managed As PV evolves from manual reactive workflows to sophisticated AIaugmented systems the imperative for comprehensive workforce upskilling grows stronger Organisations and professionals must adapt to new technical demands regulatory requirements and ethical challenges to...

    Gene Therapy: Breakthrough Treatments for Rare Diseases

    The idea of gene therapy is radically changing the sphere of medicine with the possibilities to cure the patients with the rare hereditary diseases These diseases which are usually brought about by the alteration of the sequence

    COVID-19 Vaccines & SARS-CoV-2 Variants: Who is winning the Race?

    It was not uncommon to name the year as annus horribilis as the SARSCoV quickly spread all over the globe causing the first pandemic in years leading to devastating consequences on health economy and the society in general Neither drugs nor vaccines were available for more or less the whole first year of the pandemic causing devastation helplessness and uncertainty Since the beginning of the COV...

TOP ARTICLES

  • 4

    Gene Therapy: Breakthrough Treatments for Rare Diseases

    Kate Williamson

    As a novel healing technique, gene therapy targets core issues in hereditary diseases. This is another approach where damaged genes are altered or removed; this has a ray of hope in diseases like SCID...

press releases Read more...

FairJourney Bio Delivers Antibody Engineering for Novel Tumor-Conditional IL-12 Therapeutic Approach That Unlocks the Potential of Localized Cytokine Activation

FairJourney Bio FJBio a global antibody discovery expert today announced the publication of a peerreviewed study in mAbs describing a novel approach with the potential to improve the therapeutic window of IL

Ipsen completes acquisition of Kartos Therapeutics, strengthening late-stage Oncology pipeline

Ipsen announced today it has completed the acquisition of Kartos Therapeutics a clinicalstage biopharmaceutical company adding latestage MDM inhibitor navtemadlin in Phase III clinical development in myelofibrosis

Galen and POA Pharma unveil Galsana, a new global brand for rare metabolic diseases

At the SSIEM Annual Symposium in Helsinki Galen Ltd and POA Pharma announced the launch of Galsana a new global brand for their metabolic product portfolio bringing together established products

Infex Therapeutics to present new RESP-X Phase IIa data in late-breaking session at ERS Congress 2026

Infex Therapeutics a leading antiinfectives specialist today announced that new Phase IIa study data for RESPX INFEX its firstinclass antivirulence monoclonal antibody therapy in development for NCFB patients

25 - 27

Aug 2026

CPHI Korea 2026

COEX, Seoul, Korea

26 - 27

Aug 2026

BIOMEDevice 2026

Boston Convention & Exhibition...

03 - 05

Sep 2026

5th MENA Congress for Rare Diseases 2026

Beach Rotana Hotel, Abu Dhabi,...

14 - 15

Sep 2026

16th American DDF Summit

Omni Boston Hotel at the Seapo...

15 - 17

Sep 2026

COPD Drug Development Summit 2026

Street, Boston, MA 02210, USA

21 - 23

Sep 2026

21 - 23

Sep 2026

Cancer R&D World Conference

Hilton Garden Inn Miami Dolphi...

LATEST NEWS Read more...

Lupin and Tenpoint Therapeutics partner to commercialise YUVEZZI™ across European markets

Lupin Limited has announced that its wholly owned subsidiary VISUfarma BV has entered into an exclusive licensing agreement with Visus Therapeutics Inc a wholly owned subsidiary of Tenpoint Therapeutics Holding Limited

Rein Therapeutics receives US FDA Fast Track designation for LTI-03 in idiopathic pulmonary fibrosis

Rein Therapeutics has received Fast Track designation from the US Food and Drug Administration FDA for LTI an investigational treatment being developed for idiopathic pulmonary fibrosis IPF

IDEAYA Biosciences Announces Clinical Collaboration with Genentech for MTAP-Deleted, KRAS G12D-Mutant Pancreatic Cancer

IDEAYA Biosciences Inc NASDAQ IDYA has entered into a clinical collaboration with Genentech a member of the Roche Group to evaluate IDE in combination with GDC RG in patients

NTx Bio Supports Baylor College of Medicine in Manufacturing Personalised Cancer Vaccine for Phase 1 Melanoma Trial

NTx Bio is supporting Baylor College of Medicine in the manufacturing of a personalised cancer vaccine being evaluated in Diakonos Oncologys Phase trial for patients with refractory melanoma

VectorBuilder and Lir Therapeutics partner to advance AAV capsids for clinical development

VectorBuilder and Lir Therapeutics have entered into a strategic collaboration to develop adenoassociated virus AAV capsids that combine strong biological performance with the manufacturing and scalability requirements needed for clinical development

Cytovance Biologics launches standalone analytical services for biologics development

Cytovance Biologics has expanded its analytical services portfolio to provide standalone analytical support for biotechnology and pharmaceutical companies The new offering gives clients access to Cytovances analytical expertise and regulatoryready solutions without requiring a manufacturing engageme...